Barclays Maintains Equal-Weight on Progyny, Lowers Price Target to $30

Benzinga · 2d ago
Barclays analyst Peter Warendorf maintains Progyny (NASDAQ:PGNY) with a Equal-Weight and lowers the price target from $34 to $30.